Glaucoma: Current and New Therapeutic Approaches.

Autor:	Lee HP; Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan., Tsung TH; Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan., Tsai YC; Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.; Department of Ophthalmology, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan., Chen YH; Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan., Lu DW; Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
Jazyk:	angličtina
Zdroj:	Biomedicines [Biomedicines] 2024 Sep 03; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 03.
DOI:	10.3390/biomedicines12092000
Abstrakt:	Glaucoma is identified by the loss of retinal ganglion cells (RGCs). The primary approach to managing glaucoma is to control intraocular pressure (IOP). Lately, there has been an increasing focus on neuroprotective therapies for glaucoma because of the limited effectiveness of standard methods in reducing IOP and preventing ongoing vision deterioration in certain glaucoma patients. Various drug-based techniques with neuroprotective properties have demonstrated the ability to decrease the mortality of retinal ganglion cells. This study will analyze the currently recommended drug-based techniques for neuroprotection in the prospective treatment of glaucoma.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu